Celestica Shares Slip 1.7% as Analysts Raise Targets and Insider Sales Reported

Celestica Inc. (NYSE: CLS) fell 1.7% in mid‑day trading, touching a low of $353.82 and closing around $354.63 on lower-than‑average volume. Several Wall Street firms upgraded their outlook: Barclays lifted its price objective to $441, RBC to $440, TD Cowen and TD Securities to $430, and UBS to $400. The stock now carries an overall “Buy” consensus with a median target of $427.42.

The company posted quarterly earnings of $2.16 per share, beating estimates by $0.08, and revenue of $3.96 billion, just shy of the $3.97 billion consensus but up 52.8% year‑over‑year. Management projected FY 2026 earnings of $10.15 per share and Q2 2026 earnings between $2.14 and $2.34 per share.

Insider activity showed CEO Robert Mionis sold 66,056 shares at an average price of $400.06, a $26.4 million transaction that reduced his stake by roughly 33%. Director Michael Max Wilson also divested 4,168 shares at $333.31 each, totaling $1.39 million and lowering his holding by about 14%.